The role of phosphatases, in particular Protein Tyrosine Phosphatases or PTP (and to a less extent, Dual Specific Phosphatases, DUSP), as tumour suppressors have been studied for decades and are emerging targets for novel technologies for oncogenic therapy [81, 92]. The gene discussed is PTEN; the disease is neoplasm.